Payahoo L, Ostadrahimi A, Mobasseri M, Khajebishak Y, Jafarabadi MA, Mahdavi AB. Sepide Mahluji, Anethum graveolens L. supplementation has anti-inflammatory effect in type 2 diabetic patients. Indian J Tradit Knowl. 2014;13(3):461–5.

Google Scholar 

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:107843.

Article  PubMed  Google Scholar 

Hazar N, Jokar M, Namavari N, Hosseini S, Rahmanian V. An updated systematic review and meta-analysis of the prevalence of type 2 diabetes in Iran, 1996–2023. Front Public Health. 2024;12:1322072.

Article  PubMed  PubMed Central  Google Scholar 

American Diabetes Association. Diagnosis and classification of diabetes mellitus, Diabetes care. 33;(Supplement_1):2010;S62–9.

Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440(7086):944–8.

Article  CAS  PubMed  Google Scholar 

E.C.o.t. Diagnosis, C.o.D. Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(suppl_1):s5–20.

Article  Google Scholar 

Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17:1–19.

Article  Google Scholar 

Martin CL, Albers JW, Pop-Busui R, D.E.r. Group. Neuropathy and related findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care. 2014;37(1):31–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(3):293–301.

Article  PubMed  Google Scholar 

Atlas D, International Diabetes Federation. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation, 2015, Eur Respir J 2006;27:188–207.

Lipscombe LL. Thiazolidinediones: do harms outweigh benefits? CMAJ. 2009;180(1):16–7.

Article  PubMed  Google Scholar 

Endo Y, Suzuki M, Yamada H, Horita S, Kunimi M, Yamazaki O, Shirai A, Nakamura M, Iso-O N, Li Y. Thiazolidinediones enhance sodium-coupled bicarbonate absorption from renal proximal tubules via PPARγ-dependent nongenomic signaling. Cell Metabol. 2011;13(5):550–61.

Article  CAS  Google Scholar 

Tutunchi H, Asghari Jafarabadi M, Hoojeghani S, Tabrizi S, Farrin N, Payahoo L, Ostadrahimi A. General and abdominal obesity is related to socioeconomic status and food choices: a cross-sectional study. Nutr Food Sci. 2020;50(1):61–73.

Article  Google Scholar 

Cheng AY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ. 2005;172(2):213–26.

Article  PubMed  PubMed Central  Google Scholar 

Nicholson G, Hall G. Diabetes mellitus: new drugs for a new epidemic. Br J Anaesth. 2011;107(1):65–73.

Article  CAS  PubMed  Google Scholar 

Verspohl E. Novel pharmacological approaches to the treatment of type 2 diabetes. Pharmacol Rev. 2012;64(2):188–237.

Article  CAS  PubMed  Google Scholar 

Ostadrahimi A, Payahoo L, Somi MH, Khajebishak Y. The association between urinary cadmium levels and dietary habits with risk of gastrointestinal cancer in Tabriz, Northwest of Iran. Biol Trace Elem Res. 2017;175(1):72–8.

Article  CAS  PubMed  Google Scholar 

Pandey M, Verma RK, Saraf SA. Nutraceuticals: new era of medicine and health. Asian J Pharm Clin Res. 2010;3(1):11–5.

Google Scholar 

Ghalichi F S-A, Kafil B, Faghfouri AH, Rajabi Jourshari M, Akbari Naserkiadeh A, Ostadrahimi A. Insulin receptor substrates regulation and clinical responses following vanadium-enriched yeast supplementation in obese type 2 diabetic patients: a randomized, double-blind, placebo-controlled clinical trial. Biol Trace Elem Res. 2023;201:5169–5182. https://doi.org/10.1007/s12011-023-03604-4

Article  PubMed  Google Scholar 

Ghalichi OAF, Saghafi-Asl M. Vanadium and diabetic dyslipidemia: a systematic review of animal studies. J Trace Elem Med Biol. 2022;26:126955.

Article  Google Scholar 

Delpino FM, Figueiredo LM. Resveratrol supplementation and type 2 diabetes: a systematic review and meta-analysis. Critical reviews in food science and nutrition. 2022;62(16):4465–80.

Article  CAS  PubMed  Google Scholar 

Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell. 2006;127(6):1109–22.

Article  CAS  PubMed  Google Scholar 

Um J-H, Park S-J, Kang H, Yang S, Foretz M, McBurney MW, Kim MK, Viollet B, Chung JH. AMP-activated protein kinase–deficient mice are resistant to the metabolic effects of resveratrol. Diabetes. 2010;59(3):554–63.

Article  CAS  PubMed  Google Scholar 

Burns J, Yokota T, Ashihara H, Lean ME, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem. 2002;50(11):3337–40.

Article  CAS  PubMed  Google Scholar 

Zare Javid A, Hormoznejad R, Yousefimanesh HA, Zakerkish M, Haghighi-zadeh MH, Dehghan P, et al. The impact of resveratrol supplementation on blood glucose, insulin, insulin resistance, triglyceride, and periodontal markers in type 2 diabetic patients with chronic periodontitis. Phytotherapy research. 2017;31(1):108–14.

Article  CAS  PubMed  Google Scholar 

Park S-J, Ahmad F, Philp A, Baar K, Williams T, Luo H, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell. 2012;148(3):421–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cucciolla V, Borriello A, Oliva A, Galletti P, Zappia V, Ragione FD. Resveratrol: from basic science to the clinic. Cell cycle. 2007;6(20):2495–510.

Article  CAS  PubMed  Google Scholar 

Silan C. The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats. Biol Pharm Bull. 2008;31(5):897–902.

Article  CAS  PubMed  Google Scholar 

Poussier B, Cordova AC, Becquemin J-P, Sumpio BE. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J Vasc Surg. 2005;42(6):1190-1190. e14.

Article  PubMed  Google Scholar 

Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Förstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation. 2002;106(13):1652–8.

Article  CAS  PubMed  Google Scholar 

Brasnyó P, Molnár GA, Mohás M, Markó L, Laczy B, Cseh J, et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 2011;106(3):383–9.

Article  PubMed  Google Scholar 

Gu W, Geng J, Zhao H, Li X, Song G. Effects of resveratrol on metabolic indicators in patients with type 2 diabetes: a systematic review and meta-analysis. Int J Clin Pract. 2022;2022(1):9734738.

Article  PubMed  PubMed Central  Google Scholar 

Rüweler M, Gülden M, Maser E, Murias M, Seibert H. Cytotoxic, cytoprotective and antioxidant activities of resveratrol and analogues in C6 astroglioma cells in vitro. Chem Biol Interact. 2009;182(2–3):128–35.

Article  PubMed  Google Scholar 

Kumar A, Kaundal RK, Iyer S, Sharma SS. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci. 2007;80(13):1236–44.

Article  CAS  PubMed  Google Scholar 

Liu K, Zhou R, Wang B, Mi M-T. Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr. 2014;99(6):1510–9.

Article  CAS